InvestorsHub Logo
Post# of 251718
Next 10
Followers 97
Posts 92809
Boards Moderated 4
Alias Born 10/29/2007

Re: None

Thursday, 03/27/2014 8:25:08 AM

Thursday, March 27, 2014 8:25:08 AM

Post# of 251718
Alimera resubmits NDA
Alimera Sciences (ALIM) resubmits its NDA for ILUVIEN after receiving a CRL from the regulator in October.
The product is approved for sale in the UK, Portugal, France, Germany and Spain, but is commercially available only in the UK and Germany.
Consensus revenue estimates for 2014 and 2015 are $13.7M and $36.2M, respectively.
73 mutual funds have positions, up from 23 a year earlier.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.